Status: Completed
ClinicalTrials.gov Identifier: NCT00891735
Harbor: Ranibizumab Injections administered on monthly or as needed basis in patients with wet AMD.
Condition: Age-Related Macular Degeneration
Study Type: Interventional
Duration: 3 years
Eligibility:
For additional information on this study, please click here
Back to Clinical Research